These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7592688)

  • 1. The Ser36-Ser37 pair in HeLa nuclear protein p21/SIIR mediates Ser/Thr phosphorylation and is essential for Rous sarcoma virus long terminal repeat repression.
    Yeh CH; Zong WX; Shatkin AJ
    J Biol Chem; 1995 Oct; 270(43):25313-5. PubMed ID: 7592688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein.
    Yeh CH; Shatkin AJ
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11002-6. PubMed ID: 7971997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cis-acting element in Rous sarcoma virus long terminal repeat required for promoter repression by HeLa nuclear protein p21.
    Yeh CH; Shatkin AJ
    J Biol Chem; 1995 Jun; 270(26):15815-20. PubMed ID: 7797584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity.
    Mobley CM; Sealy L
    J Virol; 1998 Aug; 72(8):6592-601. PubMed ID: 9658104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chicken YB-2, a Y-box protein, is a potent activator of Rous sarcoma virus long terminal repeat-driven transcription in avian fibroblasts.
    Swamynathan SK; Nambiar A; Guntaka RV
    J Virol; 1997 Apr; 71(4):2873-80. PubMed ID: 9060644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.
    Mobley CM; Sealy L
    J Virol; 2000 Jul; 74(14):6511-9. PubMed ID: 10864664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.
    Houtz EK; Conklin KF
    J Virol; 1996 Jan; 70(1):393-401. PubMed ID: 8523553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
    Banders UT; Coussens PM
    Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1 binding sites inserted into the rous sarcoma virus long terminal repeat enhance LTR-driven gene expression.
    Machon O; Strmen V; Hejnar J; Geryk J; Svoboda J
    Gene; 1998 Feb; 208(1):73-82. PubMed ID: 9479051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers.
    Ryden TA; de Mars M; Beemon K
    J Virol; 1993 May; 67(5):2862-70. PubMed ID: 8386280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of the Rous sarcoma virus long terminal repeat promoter by Marek's disease virus.
    Tieber VL; Zalinskis LL; Silva RF; Finkelstein A; Coussens PM
    Virology; 1990 Dec; 179(2):719-27. PubMed ID: 2173259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the rous sarcoma virus long terminal repeat-driven transcription by in vitro methylation: different sensitivity in permissive chicken cells versus mammalian cells.
    Hejnar J; Plachý J; Geryk J; Machon O; Trejbalová K; Guntaka RV; Svoboda J
    Virology; 1999 Mar; 255(1):171-81. PubMed ID: 10049832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing physiological variations in the activity of the Rous sarcoma virus long terminal repeat.
    Lang A; Fincham VJ; Wyke JA
    Virology; 1993 Oct; 196(2):564-75. PubMed ID: 8396803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and defective components of avian endogenous virus long terminal repeat enhancer sequences.
    Habel DE; Dohrer KL; Conklin KF
    J Virol; 1993 Mar; 67(3):1545-54. PubMed ID: 8382309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
    Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
    Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.
    Kumar V; Jayasuryan N; Kumar R
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5647-52. PubMed ID: 8643631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of nuclear proteins that bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat.
    Sears RC; Sealy L
    J Virol; 1992 Nov; 66(11):6338-52. PubMed ID: 1328670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
    Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
    Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro.
    Greuel BT; Sealy L; Majors JE
    Virology; 1990 Jul; 177(1):33-43. PubMed ID: 2162108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.